[Relationship between certain oxidation-reduction effects of catecholamines].
D000818:Animals; D002395:Catecholamines / Q000008:administration & dosage / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D007279:Injections, Subcutaneous; D008099:Liver / Q000098:blood supply / Q000378:metabolism; D008297:Male; D051379:Mice; D009132:Muscles / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects*; D012039:Regional Blood Flow / Q000187:drug effects; D013154:Spleen / Q000098:blood supply / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000378:metabolism
D002395:Catecholamines; D013438:Sulfhydryl Compounds; D009638:Norepinephrine; D004837:Epinephrine
Vzaĭmosviaz' mezhdu nekotorymi okislitel'no-vosstanovitel'nymi effektami katekholaminov